Phase 1b Trial of Tarextumab (OMP 59R5) (anti-Notch 2 3 antibody) in Combination with Etoposide and Cisplatin (EP) in Patients (pts) with Untreated Extensive-Stage Small-Cell Lung Cancer (ED-SCLC): PINNACLE Study M Cathe - Notch-2 - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2014-09-25 16:16:58		Phase 1b Trial of Tarextumab (OMP 59R5) (anti-Notch 2/3 antibody) in Combination with Etoposide and Cisplatin (EP) in Patients (pts) with Untreated Extensive-Stage Small-Cell Lung Cancer (ED-SCLC): PINNACLE Study M Cathe Add to Reading List Source URL: s3.amazonaws.com Download Document from Source Website File Size: 460,20 KB Share Document on Facebook